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Background. Fibromyalgia (FM) is a chronic syndrome characterized by widespread musculoskeletal pain 
associated with other symptoms such as psychological distress and alexithymia. We aimed at evaluating 
whether the presence of alexithymia could be considered a discriminant factor to identify different sub-
types of FM.  
Methods. One hundred eighty-five FM female patients were recruited at the “A.O.U. Città della Salute e 
della Scienza” Hospital of Turin and assessed with the Visual Analog Scale (VAS) for pain and the Toronto 
Alexithymia Scale (TAS-20) for alexithymia. Psychological distress was assessed using the Hospital Anxiety 
and Depression Scale (HADS), the Distress Thermometer (DT) and the Perceived Stress Scale (PSS). The 
Short-Form 36 Health Survey (SF-36) was used for patients’ quality of life.  
Results. Patients had a mean (SD) age of 52.1 (10.4) years and a mean duration of the disease of 107.54 
(98.7) months. The TAS-20 showed the presence of alexithymia in 25.9% of the patients (48/185) (FM_A 
group). The comparison between FM_A and FM patients without alexithymia (FM_nA) revealed that the 
FM_A group had statistically significant higher scores in the VAS (p=.003), in the HADS (p<.001), in the DT 
(p<.001) and in the PSS (p<.001), and statistically significant lower scores in the majority of the sub-scales 
of the SF-36 (p<.05), suggesting a worse quality of life. 
Conclusion. The presence of alexithymia could be considered a discriminant factor that identifies a sub-
type of FM patients characterized both by higher pain and higher psychological distress. 
 
 
